Literature DB >> 8509801

Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study.

K Radhakrishnan1, A K Thacker, N H Bohlaga, J C Maloo, S E Gerryo.   

Abstract

An epidemiologic survey of idiopathic intracranial hypertension (IIH) in Benghazi, Libya, over a period from September 1982 through August 1989 ascertained 81 patients. The group was comprised of 76 females and 5 males. Ages ranged from 8 to 55 years; the mean +/- S.D. was 28.6 +/- 7.9 for women and 21.0 +/- 14.5 for men. The average crude annual incidence rates for IIH per 100,000 persons were 2.2 for the total and 4.3 for females for all ages (3.2 for the total and 5.9 for the females when adjusted to the 1980 United States population). In females aged 15-44 years, IIH occurred at a rate of 12.0 per 100,000 per year; for those defined as obese, the rate rose to 21.4. Moderate to severe visual loss occurred as a sequelae in 20% of our patients. The extent of visual loss did not correlate with age at diagnosis, duration of symptoms, degree of obesity, use of oral contraceptive pills, cerebrospinal fluid (CSF) opening pressure, steroid treatment, or recurrence. We found no correlation between CSF protein and opening pressure. We conducted a case-control study on 40 consecutive female incident IIH patients and 80 age-matched female control subjects. Obesity and recent weight gain occurred more frequently in patients. More patients were married and more had irregular menses. The incidence rate for IIH described in our study is three to four times higher than that reported from the United States.

Entities:  

Mesh:

Year:  1993        PMID: 8509801     DOI: 10.1016/0022-510x(93)90084-c

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  51 in total

Review 1.  New developments in idiopathic intracranial hypertension.

Authors:  R K Shin; L J Balcer
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

Review 2.  Incidence of papilledema and obesity in children diagnosed with idiopathic ''benign'' intracranial hypertension: case series and review.

Authors:  Gabriel Faz; Ian J Butler; Mary Kay Koenig
Journal:  J Child Neurol       Date:  2010-03-31       Impact factor: 1.987

3.  Incidence of cerebellar tonsillar ectopia in idiopathic intracranial hypertension: a mimic of the Chiari I malformation.

Authors:  A H Aiken; J A Hoots; A M Saindane; P A Hudgins
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-21       Impact factor: 3.825

4.  Risk of intracranial hypertension with intrauterine levonorgestrel: reply.

Authors:  Mahyar Etminan
Journal:  Ther Adv Drug Saf       Date:  2016-02

5.  Idiopathic intracranial hypertension is not benign: a long-term outcome study.

Authors:  Hanne M Yri; Marianne Wegener; Birgit Sander; Rigmor Jensen
Journal:  J Neurol       Date:  2011-10-19       Impact factor: 4.849

6.  Racial differences in idiopathic intracranial hypertension.

Authors:  B B Bruce; P Preechawat; N J Newman; M J Lynn; V Biousse
Journal:  Neurology       Date:  2008-03-11       Impact factor: 9.910

7.  Alterations in the cerebral venous circulation as a cause of headache.

Authors:  Elio Agostoni; Angelo Aliprandi
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

8.  Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension.

Authors:  Laura J Edwards; Basil Sharrack; Azza Ismail; Christopher R Tench; Bruno Gran; Samish Dhungana; Johannes Brettschneider; Hayrettin Tumani; Cris S Constantinescu
Journal:  Am J Clin Exp Immunol       Date:  2013-10-16

9.  The Photopic Negative Response in Idiopathic Intracranial Hypertension.

Authors:  Heather E Moss; Jason C Park; J Jason McAnany
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

Review 10.  An Up to Date Review of Pseudotumor Cerebri Syndrome.

Authors:  John Glenn Burkett; Jessica Ailani
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-02       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.